BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3289603)

  • 1. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.
    Niederwieser D; Pepe M; Storb R; Loughran TP; Longton G
    Br J Haematol; 1988 May; 69(1):23-8. PubMed ID: 3289603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
    Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
    Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
    Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
    Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
    Storb R; Deeg HJ; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
    Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.
    Cesaro S; Peffault de Latour R; Tridello G; Pillon M; Carlson K; Fagioli F; Jouet JP; Koh MB; Panizzolo IS; Kyrcz-Krzemien S; Maertens J; Rambaldi A; Strahm B; Blaise D; Maschan A; Marsh J; Dufour C;
    Br J Haematol; 2015 Nov; 171(4):606-14. PubMed ID: 26304743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival following bone marrow transplantation for aplastic anaemia.
    Feig SA; Champlin R; Arenson E; Yale C; Ho W; Tesler A; Gale RP
    Br J Haematol; 1983 Aug; 54(4):509-17. PubMed ID: 6347239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?
    Gallo S; Woolfrey AE; Burroughs LM; Storer BE; Flowers ME; Hari P; Pulsipher MA; Heimfeld S; Kiem HP; Sandmaier BM; Storb R
    Bone Marrow Transplant; 2016 Dec; 51(12):1573-1578. PubMed ID: 27479689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.
    Storb R; Prentice RL; Thomas ED
    J Clin Invest; 1977 Apr; 59(4):625-32. PubMed ID: 14972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group.
    McCann SR; Bacigalupo A; Gluckman E; Hinterberger W; Hows J; Ljungman P; Marin P; Nissen C; van't Veer Kerthof E; Raghavachar A
    Bone Marrow Transplant; 1994 Mar; 13(3):233-7. PubMed ID: 8199566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation experience for children with aplastic anemia.
    Sanders JE; Whitehead J; Storb R; Buckner CD; Clift RA; Mickelson E; Appelbaum FR; Bensinger WI; Stewart PS; Doney K
    Pediatrics; 1986 Feb; 77(2):179-86. PubMed ID: 3511444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow transplantation in hepatitis-associated aplastic anemia.
    Witherspoon RP; Storb R; Shulman H; Buckner CD; Deeg HJ; Clift RA; Sanders JE; Doney K; McDonald G; Sullivan KM
    Am J Hematol; 1984 Oct; 17(3):269-78. PubMed ID: 6383025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.
    Storb R; Prentice RL; Sullivan KM; Shulman HM; Deeg HJ; Doney KC; Buckner CD; Clift RA; Witherspoon RP; Appelbaum FA; Sanders JE; Stewart PS; Thomas ED
    Ann Intern Med; 1983 Apr; 98(4):461-6. PubMed ID: 6340576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late graft rejection and second infusion of bone marrow in children with aplastic anaemia.
    Eapen M; Davies SM; Ramsay NK
    Br J Haematol; 1999 Jan; 104(1):186-8. PubMed ID: 10027732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.